Trump greenlights NVIDIA chip sales to China
Digest more
At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to accelerate drug discovery and automate laboratory infrastructure globally.
On Tuesday, the Donald Trump administration formally approved Nvidia Corporation's (NASDAQ:NVDA) sales of its H200 artificial intelligence chips to China. US Approves H200 Exports Under New Guardrails The approval allows Nvidia to resume shipments of its H200 chips to China,
In a corporate partnership many investors didn't see coming, chip maker Nvidia ( NVDA +1.59%) and pharmaceutical company Eli Lilly ( LLY +0.29%) say they are collaborating to build and operate a joint research lab. This plan was unveiled at the annual JPMorgan Healthcare Conference in January.
SiFive, which makes blueprints for parts of complex chips, said on Thursday it will become the first maker of RISC-V chip designs to integrate Nvidia technology that creates speedy links between chips.
Nvidia is rolling out a new app update today that includes its latest DLSS 4.5 Super Resolution and Nvidia Surround settings. DLSS 4.5 includes Nvidia’s second-generation Super Resolution transformer model, designed to improve image quality and reduce the artifacting found in DLSS 4.
SiFive has announced a partnership with Nvidia to integrate Nvidia’s NVLink Fusion interconnect technology into its forthcoming silicon platforms.
Duquesne Family Office's billionaire boss jettisoned his entire stake in the face of the artificial intelligence (AI) revolution in favor of another industry-leading company.